Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 1.00 |
| ▸ | AR | P10275 | 5/20 | 0.73 |
| ▸ | ACHE | P22303 | 1/20 | 0.63 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.63 |
| ▸ | MAOA | P21397 | 1/20 | 0.62 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.62 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15630203 | 1.00 | MAOB (1.00) | MAOBARACHEABCG2MAOA | |
| SCHEMBL15619197 | 0.86 | MAOB (0.76) | MAOBARACHEABCG2MAOA | |
| SCHEMBL15619198 | 0.86 | MAOB (0.76) | MAOBARACHEABCG2MAOA | |
| SCHEMBL15619317 | 0.86 | MAOB (0.75) | MAOBARACHEABCG2NR1H4 | |
| SCHEMBL5137641 | 0.86 | MAOB (0.75) | MAOBARACHEABCG2MAOA | |
| SCHEMBL15619316 | 0.86 | MAOB (0.75) | MAOBARACHEABCG2NR1H4 | |
| SCHEMBL5137643 | 0.86 | MAOB (0.75) | MAOBARACHEABCG2MAOA | |
| SCHEMBL15630178 | 0.85 | MAOB (0.74) | MAOBARACHEABCG2MAOA | |
| SCHEMBL16928595 | 0.85 | MAOB (0.74) | MAOBARACHEABCG2MAOA | |
| SCHEMBL15620265 | 0.85 | MAOB (0.73) | MAOBARACHEABCG2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9629822-B2 | Flavonoid based antiviral targets | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2017-04-25 | — | — | US | disclosed |
| US-20150209323-A1 | FLAVONOID BASED ANTIVIRAL TARGETS | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, (US) | 2015-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150209323-A1 | FLAVONOID BASED ANTIVIRAL TARGETS | RBM28, MAVS, HAVCR2 | MAOB 4153/4885AR 4201/4885ACHE 4849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.